원격 환자 모니터링 시장 예측(-2034년) : 구성요소, 제품 유형, 적응증, 제공 형태, 모니터링 방식, 전송 방식, 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Remote Patient Monitoring Market is accounted for $38.3 billion in 2026 and is expected to reach $102.7 billion by 2034 growing at a CAGR of 13.1% during the forecast period. Remote patient monitoring (RPM) involves the use of digital technologies to collect patient health data outside traditional clinical settings, transmitting information such as vital signs, blood glucose levels, and heart rhythms to healthcare providers for real-time assessment. This market encompasses wearable devices, mobile health applications, and centralized platforms that enable continuous or intermittent tracking of chronic conditions. RPM is transforming healthcare delivery by reducing hospital readmissions, improving patient engagement, and enabling proactive interventions that enhance clinical outcomes while lowering system-wide costs.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases globally

The growing burden of conditions such as diabetes, hypertension, cardiovascular disease, and chronic respiratory disorders is creating urgent demand for scalable, cost-effective care management solutions. Traditional episodic care models struggle to accommodate the millions of patients requiring continuous monitoring, leading to frequent hospitalizations and escalating healthcare expenditures. RPM offers a practical alternative by enabling daily tracking of physiological parameters in patients' homes, with automated alerts for concerning trends. Health systems are increasingly adopting these solutions as evidence mounts demonstrating reduced mortality rates, fewer emergency department visits, and improved medication adherence among remotely monitored chronic disease populations.

Restraint:

Data security and patient privacy concerns

The transmission and storage of sensitive health information through connected devices raises substantial risks that slow healthcare provider adoption of RPM technologies. Cyberattacks targeting medical devices and cloud platforms can expose personal health information, leading to identity theft, insurance discrimination, and reputational damage for healthcare organizations. Compliance with stringent regulations such as HIPAA, GDPR, and other regional data protection frameworks requires significant investment in encryption, access controls, and audit systems. Smaller healthcare providers, in particular, may find these requirements prohibitively expensive, while patients remain hesitant to share intimate health data through digital channels, creating a significant barrier to widespread RPM deployment.

Opportunity:

Integration of artificial intelligence for predictive analytics

Advanced machine learning algorithms are unlocking the full potential of remote patient monitoring by transforming raw physiological data into actionable clinical insights. AI models can identify subtle patterns preceding acute events, such as sepsis, heart failure exacerbation, or respiratory decline, enabling preemptive interventions before emergency situations develop. These systems continuously learn from aggregated patient populations, improving predictive accuracy over time and reducing false alarms that contribute to clinician alert fatigue. As reimbursement models increasingly reward preventative care and value-based outcomes, healthcare organizations are investing heavily in AI-enhanced RPM platforms that demonstrate clear return on investment through reduced hospitalizations and improved chronic disease management.

Threat:

Interoperability challenges across healthcare systems

The fragmentation of electronic health record (EHR) platforms and medical device standards creates significant obstacles to seamless RPM integration within existing clinical workflows. Patient monitoring data collected through various vendors often cannot communicate with hospital information systems without costly custom interfaces or manual data entry, negating efficiency benefits. This lack of interoperability forces clinicians to access multiple separate applications, increasing documentation burden rather than reducing it. As healthcare organizations expand RPM programs across diverse patient populations, the inability to aggregate and analyze data from heterogeneous sources limits the clinical utility of monitoring programs, potentially slowing adoption rates despite strong evidence supporting remote care models.

Covid-19 Impact:

The COVID-19 pandemic triggered unprecedented acceleration in remote patient monitoring adoption as healthcare systems urgently sought alternatives to in-person care delivery. Lockdowns, patient fears of infection, and overwhelmed hospital capacity made RPM essential for managing both COVID-19 patients and those with chronic conditions requiring ongoing surveillance. Regulatory bodies temporarily relaxed telehealth restrictions, while payers expanded reimbursement for remote monitoring services, removing longstanding financial barriers. This forced experimentation demonstrated RPM's clinical effectiveness and patient acceptance, with many temporary policies made permanent post-pandemic. The experience fundamentally shifted provider and patient attitudes, establishing RPM as a standard care component rather than a niche offering.

The Cloud-Based segment is expected to be the largest during the forecast period

The Cloud-Based segment is expected to account for the largest market share during the forecast period, driven by the scalability, accessibility, and lower upfront costs of cloud deployment models. Healthcare organizations increasingly prefer cloud solutions for remote monitoring because they eliminate expensive on-site server infrastructure, enable automatic software updates, and facilitate secure data access from any location. Cloud platforms excel at aggregating patient data from diverse devices and locations, supporting the large-scale population health analytics essential for value-based care programs. The subscription pricing model aligns with operational budgets rather than capital expenditures, making cloud-based RPM accessible to smaller clinics and rural healthcare facilities that would otherwise struggle with on-premise alternatives.

The Continuous Monitoring segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Continuous Monitoring segment is predicted to witness the highest growth rate, reflecting technological advances enabling uninterrupted, real-time data collection from wearable sensors. Unlike intermittent monitoring, which captures snapshots at specific intervals, continuous solutions provide complete physiological trend data, detecting subtle changes that may signal deterioration hours or days before clinical symptoms emerge. This capability is particularly valuable for managing high-risk cardiac patients, neonatal intensive care graduates, and individuals with seizure disorders. Falling costs of miniaturized sensors, extended battery life, and improved wireless connectivity are making continuous monitoring increasingly practical for home use, expanding its application beyond hospital settings and driving accelerated adoption across chronic disease populations.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by advanced healthcare infrastructure, favorable reimbursement policies, and high chronic disease prevalence. The United States, in particular, has seen rapid RPM adoption driven by the Centers for Medicare & Medicaid Services expanding coverage for remote monitoring services. Major technology companies and medical device manufacturers headquartered in the region continuously innovate, bringing new RPM solutions to market. The shift toward value-based payment models, which reward outcomes rather than procedures, creates strong financial incentives for healthcare systems to invest in monitoring technologies that prevent costly hospitalizations. These converging factors ensure North America maintains market leadership throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapidly aging populations, rising healthcare expenditures, and expanding internet connectivity across previously underserved areas. Countries including China, India, and Japan are witnessing dramatic increases in lifestyle-related chronic diseases such as diabetes and hypertension, overwhelming traditional healthcare delivery models. Government initiatives promoting digital health infrastructure, including national telehealth programs and smart hospital networks, create favorable conditions for RPM deployment. The region's large rural populations, often located far from specialized medical centers, stand to benefit enormously from remote monitoring that enables specialist access without travel. As local manufacturers produce affordable RPM devices suited to regional needs, Asia Pacific emerges as the fastest-growing market.

Key players in the market

Some of the key players in Remote Patient Monitoring Market include Medtronic plc, Philips Healthcare, GE HealthCare Technologies Inc., Siemens Healthineers AG, ResMed Inc., Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Masimo Corporation, OMRON Healthcare, Inc., Dexcom, Inc., iRhythm Technologies, Inc., BioTelemetry, Inc., Honeywell Life Sciences, and Garmin Ltd.

Key Developments:

In March 2026, Philips launched IntraSight Plus, a platform designed to simplify coronary interventions and advance precision care through integrated imaging and data.

In February 2026, ResMed reported that its AirView(TM) and myAir(TM) platforms have surpassed 20 million connected patients, reinforcing its position as a leader in remote monitoring for sleep apnea and respiratory care.

In January 2026, Abbott announced the integration of its FreeStyle Libre 3 sensor data with several leading hospital RPM platforms, allowing clinicians to monitor glucose levels of non-critical hospitalized patients remotely.

Components Covered:

• Devices
• Software
• Services

Product Types Covered:

• Wearable Devices
• Implantable Devices
• Handheld & Portable Devices
• Stationary Devices

Indications Covered:

• Cardiovascular Diseases
• Diabetes
• Respiratory Disorders
• Neurological Disorders
• Cancer
• Other Chronic Conditions

Mode of Deliveries Covered:

• Cloud-Based
• On-Premise

Monitoring Types Covered:

• Continuous Monitoring
• Intermittent Monitoring

Transmission Types Covered:

• Wired Monitoring
• Wireless Monitoring

Applications Covered:

• Cardiology
• Diabetes Management
• Hypertension
• Chronic Respiratory Diseases
• Neurology
• Oncology
• Sleep Disorders
• Fitness & Wellness Monitoring
• Other Applications

End Users Covered:

• Healthcare Providers
• Home Healthcare Settings
• Patients
• Healthcare Payers
• Pharmaceutical & Biotechnology Companies
• MedTech Companies
• Government & Research Organizations

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Remote Patient Monitoring Market, By Component

• 5.1 Devices
  • 5.1.1 Cardiac Monitoring Devices
  • 5.1.2 Respiratory Monitoring Devices
  • 5.1.3 Blood Glucose Monitoring Devices
  • 5.1.4 Blood Pressure Monitoring Devices
  • 5.1.5 Neurological Monitoring Devices
  • 5.1.6 Multiparameter Monitoring Devices
  • 5.1.7 Pulse Oximeters
  • 5.1.8 Temperature Monitoring Devices
  • 5.1.9 Fetal & Neonatal Monitoring Devices
  • 5.1.10 Other Monitoring Devices
• 5.2 Software
  • 5.2.1 Data Management Platforms
  • 5.2.2 Analytics & AI Platforms
  • 5.2.3 Mobile Health (mHealth) Applications
  • 5.2.4 Cloud-Based Solutions
  • 5.2.5 On-Premise Solutions
• 5.3 Services
  • 5.3.1 Consulting Services
  • 5.3.2 Integration & Deployment
  • 5.3.3 Training & Education
  • 5.3.4 Support & Maintenance

6 Global Remote Patient Monitoring Market, By Product Type

• 6.1 Wearable Devices
• 6.2 Implantable Devices
• 6.3 Handheld & Portable Devices
• 6.4 Stationary Devices

7 Global Remote Patient Monitoring Market, By Indication

• 7.1 Cardiovascular Diseases
• 7.2 Diabetes
• 7.3 Respiratory Disorders
• 7.4 Neurological Disorders
• 7.5 Cancer
• 7.6 Other Chronic Conditions

8 Global Remote Patient Monitoring Market, By Mode of Delivery

• 8.1 Cloud-Based
• 8.2 On-Premise

9 Global Remote Patient Monitoring Market, By Monitoring Type

• 9.1 Continuous Monitoring
• 9.2 Intermittent Monitoring

10 Global Remote Patient Monitoring Market, By Transmission Type

• 10.1 Wired Monitoring
• 10.2 Wireless Monitoring
  • 10.2.1 Bluetooth
  • 10.2.2 Cellular
  • 10.2.3 Wi-Fi

11 Global Remote Patient Monitoring Market, By Application

• 11.1 Cardiology
• 11.2 Diabetes Management
• 11.3 Hypertension
• 11.4 Chronic Respiratory Diseases
• 11.5 Neurology
• 11.6 Oncology
• 11.7 Sleep Disorders
• 11.8 Fitness & Wellness Monitoring
• 11.9 Other Applications

12 Global Remote Patient Monitoring Market, By End User

• 12.1 Healthcare Providers
  • 12.1.1 Hospitals
  • 12.1.2 Clinics
  • 12.1.3 Ambulatory Care Centers
  • 12.1.4 Long-Term Care Facilities
• 12.2 Home Healthcare Settings
• 12.3 Patients
• 12.4 Healthcare Payers
• 12.5 Pharmaceutical & Biotechnology Companies
• 12.6 MedTech Companies
• 12.7 Government & Research Organizations

13 Global Remote Patient Monitoring Market, By Geography

• 13.1 North America
  • 13.1.1 United States
  • 13.1.2 Canada
  • 13.1.3 Mexico
• 13.2 Europe
  • 13.2.1 United Kingdom
  • 13.2.2 Germany
  • 13.2.3 France
  • 13.2.4 Italy
  • 13.2.5 Spain
  • 13.2.6 Netherlands
  • 13.2.7 Belgium
  • 13.2.8 Sweden
  • 13.2.9 Switzerland
  • 13.2.10 Poland
  • 13.2.11 Rest of Europe
• 13.3 Asia Pacific
  • 13.3.1 China
  • 13.3.2 Japan
  • 13.3.3 India
  • 13.3.4 South Korea
  • 13.3.5 Australia
  • 13.3.6 Indonesia
  • 13.3.7 Thailand
  • 13.3.8 Malaysia
  • 13.3.9 Singapore
  • 13.3.10 Vietnam
  • 13.3.11 Rest of Asia Pacific
• 13.4 South America
  • 13.4.1 Brazil
  • 13.4.2 Argentina
  • 13.4.3 Colombia
  • 13.4.4 Chile
  • 13.4.5 Peru
  • 13.4.6 Rest of South America
• 13.5 Rest of the World (RoW)
  • 13.5.1 Middle East
    • 13.5.1.1 Saudi Arabia
    • 13.5.1.2 United Arab Emirates
    • 13.5.1.3 Qatar
    • 13.5.1.4 Israel
    • 13.5.1.5 Rest of Middle East
  • 13.5.2 Africa
    • 13.5.2.1 South Africa
    • 13.5.2.2 Egypt
    • 13.5.2.3 Morocco
    • 13.5.2.4 Rest of Africa

14 Strategic Market Intelligence

• 14.1 Industry Value Network and Supply Chain Assessment
• 14.2 White-Space and Opportunity Mapping
• 14.3 Product Evolution and Market Life Cycle Analysis
• 14.4 Channel, Distributor, and Go-to-Market Assessment

15 Industry Developments and Strategic Initiatives

• 15.1 Mergers and Acquisitions
• 15.2 Partnerships, Alliances, and Joint Ventures
• 15.3 New Product Launches and Certifications
• 15.4 Capacity Expansion and Investments
• 15.5 Other Strategic Initiatives

16 Company Profiles

• 16.1 Medtronic plc
• 16.2 Philips Healthcare
• 16.3 GE HealthCare Technologies Inc.
• 16.4 Siemens Healthineers AG
• 16.5 ResMed Inc.
• 16.6 Abbott Laboratories
• 16.7 Boston Scientific Corporation
• 16.8 Biotronik SE & Co. KG
• 16.9 Masimo Corporation
• 16.10 OMRON Healthcare, Inc.
• 16.11 Dexcom, Inc.
• 16.12 iRhythm Technologies, Inc.
• 16.13 BioTelemetry, Inc.
• 16.14 Honeywell Life Sciences
• 16.15 Garmin Ltd.